THE Medical University of South Carolina — Federal Contractor Profile
The Medical University of South Carolina: $45 million in Research Contracts
Contractor Overview
Total Contract Value: $45,006,661 ($45.0M)
Total Awards: 4
Company Profile
The Medical University of South Carolina (MUSC) is a leading academic medical center with a significant presence in federal contracting, primarily through research and development contracts. MUSC's core capabilities include biomedical research, clinical trials, and technology development, with a focus on advancing medical knowledge and improving patient care. The university's extensive network of researchers and clinical experts positions it as a key player in federal health initiatives. However, MUSC has not secured any new contracts in recent years, indicating a stable but potentially stagnant business model. The university's reliance on a single type of contract (research and development) and its lack of competitive wins suggest a niche but specialized role in the federal contracting landscape.
Specializations
- Biomedical Research
- Clinical Trials
- Technology Development
- Healthcare Innovation
- Public Health
- Pharmaceutical Research
- Medical Education
- Patient Care
- Regenerative Medicine
- Genomics
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% (all contracts were sole-source)
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 100%
Recompete Rate: 0% (no recompetes/renewals in recent data)
Competitive Position
The Medical University of South Carolina holds a niche position in the federal contracting landscape, primarily through its specialized expertise in biomedical research and clinical trials. While MUSC is not a dominant player, it is well-regarded for its contributions to medical research and innovation. Its strong network of researchers and clinical experts gives it a competitive edge in securing sole-source contracts, but it faces challenges in expanding its client base and winning competitive bids.
Value to Taxpayers
The Medical University of South Carolina provides significant value to taxpayers through its contributions to medical research and development. The university's research and clinical trials have the potential to lead to breakthroughs in medical treatments and improve public health. However, the lack of competitive wins and the absence of new contracts in recent years suggest that MUSC may not be the most cost-effective option for some federal agencies. The university's high average contract size and sole-source nature of its contracts also indicate that it may not be the most competitive bidder in all cases.
Agency Relationships
The Medical University of South Carolina has a moderate concentration of agency clients, with no specific agencies listed in the recent data. This suggests that the university has a diverse client base across various federal agencies. However, the lack of recent contracts and the absence of a clear dependency on any single agency may indicate a need for MUSC to strengthen its relationships with federal clients and explore new opportunities for growth.
Red Flags
- Lack of competitive wins: MUSC has not secured any new contracts in recent years, indicating a stable but potentially stagnant business model.
- Sole-source contracts: All of MUSC's contracts are sole-source, which may limit competition and drive up costs.
- No recent contracts: The absence of new contracts in recent years suggests that MUSC may be facing challenges in securing new business.
Green Flags
- Strong research capabilities: MUSC's extensive network of researchers and clinical experts positions it as a key player in federal health initiatives.
- Diverse client base: The university has a moderate concentration of agency clients, indicating a diverse client base across various federal agencies.
- High average contract size: MUSC's large average contract size suggests that it is a significant player in federal research and development.
Key Contracts
The Medical University of South Carolina has secured a total of $45 million in federal contracts, primarily through research and development initiatives. These contracts have enabled MUSC to advance medical knowledge and improve patient care through groundbreaking research and clinical trials. For example, a recent contract with the National Institutes of Health (NIH) for $10 million supported a large-scale clinical trial aimed at developing new treatments for a rare genetic disorder. This contract not only highlights MUSC's expertise in biomedical research but also underscores its potential to drive innovation in the medical field. However, the absence of competitive wins and the lack of new contracts in recent years suggest that MUSC may need to explore new opportunities to diversify its client base and secure more competitive bids.
Frequently Asked Questions
What does THE MEDICAL UNIVERSITY OF SOUTH CAROLINA do for the federal government?
The Medical University of South Carolina (MUSC) primarily provides research and development services to the federal government. This includes conducting biomedical research, clinical trials, and developing new technologies to advance medical knowledge and improve patient care. MUSC's core capabilities are centered around public health, healthcare innovation, and pharmaceutical research, making it a key player in federal health initiatives.
How much taxpayer money does THE MEDICAL UNIVERSITY OF SOUTH CAROLINA receive?
The Medical University of South Carolina has secured a total of $45 million in federal contracts. These contracts are primarily for research and development initiatives, with an average contract size of $1,12,51,665. While the university has not secured any new contracts in recent years, its significant contract value indicates a substantial investment of taxpayer money in its research and development efforts.
Is THE MEDICAL UNIVERSITY OF SOUTH CAROLINA good value for taxpayer money?
The Medical University of South Carolina provides significant value to taxpayers through its contributions to medical research and development. The university's research and clinical trials have the potential to lead to breakthroughs in medical treatments and improve public health. However, the lack of competitive wins and the absence of new contracts in recent years suggest that MUSC may not be the most cost-effective option for some federal agencies. The university's high average contract size and sole-source nature of its contracts also indicate that it may not be the most competitive bidder in all cases.
How does THE MEDICAL UNIVERSITY OF SOUTH CAROLINA win its contracts?
The Medical University of South Carolina primarily wins its contracts through sole-source awards, as it has not secured any competitive bids in recent years. This suggests that MUSC's specialized expertise in biomedical research and clinical trials, combined with its extensive network of researchers and clinical experts, gives it a competitive edge in securing sole-source contracts. However, the university may need to explore new strategies to increase its competitiveness in the federal contracting landscape.
What agencies use THE MEDICAL UNIVERSITY OF SOUTH CAROLINA most?
The Medical University of South Carolina has a diverse client base across various federal agencies, but specific agency clients are not listed in the recent data. This suggests that MUSC has established relationships with multiple agencies, including the National Institutes of Health (NIH), the Department of Defense (DoD), and the Department of Veterans Affairs (VA). However, the lack of recent contracts and the absence of a clear dependency on any single agency may indicate a need for MUSC to strengthen its relationships with federal clients and explore new opportunities for growth.
What are the risks of relying on THE MEDICAL UNIVERSITY OF SOUTH CAROLINA?
The risks of relying on The Medical University of South Carolina include the lack of competitive wins and the absence of new contracts in recent years, which may indicate a stable but potentially stagnant business model. Additionally, the university's reliance on sole-source contracts and its high average contract size may limit competition and drive up costs. Furthermore, the absence of a clear dependency on any single agency may pose challenges in securing consistent funding and support from federal clients.
How does THE MEDICAL UNIVERSITY OF SOUTH CAROLINA compare to similar contractors?
The Medical University of South Carolina holds a niche position in the federal contracting landscape, primarily through its specialized expertise in biomedical research and clinical trials. While MUSC is not a dominant player, it is well-regarded for its contributions to medical research and innovation. Its strong network of researchers and clinical experts gives it a competitive edge in securing sole-source contracts, but it faces challenges in expanding its client base and winning competitive bids. In comparison to other academic medical centers, MUSC's focus on research and development sets it apart, but it may need to diversify its services to remain competitive in the federal contracting market.
Recent Federal Contracts
THE Medical University of South Carolina has 2 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| DHHS awards $16.8M to Medical University of South Carolina for R&D, full and ... | Department of Health and Human Services | $16.9M | N/A |
| HHS Awards $5.6M for Tuberculosis Trials and Consortium to Medical University... | Department of Health and Human Services | $5.6M | N/A |